OBJECTIVE To investigate the efficiency and safety of the oxaliplatin,fluorouracil (5-FU) and leucovorin regimen (FOLFOX) in previously untreated patients with
BACKGROUND: Peripheral nerve injury may lead to neuropathic pain and cause a markedly increase expression of growth associated protein-43 (GAP-43) in the spinal